The high-risk keratoplasty patient--quo vadis?

Cornea. 1994 Jan;13(1):1-3. doi: 10.1097/00003226-199401000-00001.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Cyclosporine / administration & dosage
  • Graft Rejection / etiology
  • Graft Rejection / prevention & control
  • Graft Survival / drug effects
  • Histocompatibility Testing
  • Humans
  • Keratoplasty, Penetrating / adverse effects*
  • Risk Factors

Substances

  • Cyclosporine